Search Results - "Smiley, Angela"
-
1
Thalidomide and prednisolone versus prednisolone alone as consolidation therapy after autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the ALLG MM6 multicentre, open-label, randomised phase 3 study
Published in The Lancet. Haematology (01-12-2014)“…Summary Background We previously showed that consolidation therapy with thalidomide and prednisolone improved progression-free and overall survival in patients…”
Get full text
Journal Article -
2
Leopard: A Phase II Study of Maintenance Lenalidomide and Prednisolone Post Autologous Stem Cell Transplantation (ASCT) for Myeloma, Incorporating Minimal Residual Disease Assessments
Published in Blood (06-12-2014)“…Background Despite improved outcomes achieved with high dose melphalan conditioned ASCT for Myeloma (MM) patients, relapse is inevitable. Maintenance therapy…”
Get full text
Journal Article -
3
Thalidomide Consolidation Post Autologous Stem Cell Transplant (ASCT) For Multiple Myeloma (MM) Is Cost-Effective With Durable Survival Benefit At 5 Years Post Randomisation: Final Analysis Of The ALLG MM6 Study
Published in Blood (15-11-2013)“…Studies investigating thalidomide consolidation/maintenance strategies post ASCT in patients with MM have consistently demonstrated improvement in duration of…”
Get full text
Journal Article -
4
Leopard: A Phase II Study Of Post Autologous Stem Cell Transplantation (ASCT) Maintenance Lenalidomide and Prednisolone For Myeloma (MM), Incorporating Minimal Residual Disease (MRD) Assessments
Published in Blood (15-11-2013)“…Despite improved outcomes achieved with high dose melphalan conditioned ASCT for MM patients, relapse is inevitable. Consolidation/maintenance therapy with…”
Get full text
Journal Article